🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Stocks End Higher For Second Day; Energy, Financial, Industrial Sectors

Published 06/28/2012, 12:49 AM
Updated 07/09/2023, 06:31 AM
NDX
-
UK100
-
DJI
-
HK50
-
C
-
GC
-
HG
-
SMT
-
FTNMX551030
-
IXIC
-
OREXQ
-
VVUSQ
-
Stocks End Higher for Second Day; Energy, Financial, Industrial Sectors Climb on Positive Data

Stocks finished with broad gains for a second day, supported by positive domestic economic data ahead of the start of a European Union summit tomorrow. Shares of energy companies led today's advance, rising over 2% as a group, joined by strong results among financial, healthcare and industrial stocks. The mining and materials segment also rose, supported by a rise in gold and copper prices.

Durable-good orders showed improvement, with new factory orders rising 1.1% during May, up from 0.2% the prior month and beating consensus estimates for a 0.4% gain. For the year, new orders are up 4.6%, lagging last year's 6.9% pace.

Excluding transportation, orders of items intended to last at least three years came in at 0.4% for the month, beating April's negative 0.6% reading. Analysts, on average, were expecting 0.8% growth.

There was more good news today from the housing sector, as the pending home sales index rose from a prior level of 95.5 to 101.1. At 5.9%, it well surpassed both the previous level of -5.5% and consensus estimates of 1.2% (range -1.6% to 4.0%). Moreover, the gain was realized relatively evenly across regions, rather than being centered in one geographic location.

In company news, shares of Arena Pharmaceuticals (ANRA) soared today after regulators cleared the company's lorcaserin weight-loss drug for U.S. sales, becoming the first new prescription diet pill approved in this country in 13 years.

The move by the U.S. Food and Drug Administration sent shares of other drug-makers working on similar weight-loss medication highers as well. Vivus (VVUS) established a new 52-week high with the FDA expected to rule July 17 its Qnexa diet drug. Also rising was Orexigen Therapeutics (OREX).

Also traded, Google (GOOG) finished with a small gain, with the company today unveiling its entry into the tablet computer market. The Nexus Seven is designed specifically for Google Play, the online store that sells movies, music, books, apps and other media content. GOOG also announced a home entertainment device called Nexus Q.

Here's where the markets stood at end-of-day:

Dow Jones Industrial Average up 92.34 (+0.74%) to 12,627.01

S&P 500 up 11.86 (+0.90%) to 1,331.85

Nasdaq Composite Index up 21.26 (+0.74%) to 2,875.32

GLOBAL SENTIMENT

Hang Seng Index up 1.03%

Shanghai China Composite Index down 0.23%

FTSE 100 Index up 1.41%

UPSIDE MOVERS

(+) ZZ, Q2 profit tops analyst consensus by $0.02. Revenue also beats estimates.

(+) NWSA, Hires JPMorgan, Goldman Sachs to advise on possible spinoff of publishing, entertainment operations.

(+) HERO, Initiated with Equal Weight rating, $5 price target, at Stephens.

(+) LEN, Q2 net income soars on a tax adjustment; deliveries, new orders also increase.

(+) ENTR, Raises Q2 guidance, now sees $81 million to $82 million in sales; $0.08 a share projected profit tops analyst consensus by $0.05.

DOWNSIDE MOVERS

(-) GIS, Q4 EPS beats by $0.01 but sales lag forecasts. FY13 earnings guidance also trails Street.

(-) ORLY, Auto-parts retailer cuts Q2 same-store guidance, now sees 2.0% to 2.5% growth. Rivals AAP, AZO also fall but PBY rises.

(-) M, Citigroup downgrades retailer to Neutral. JWN, SKS ratings also cut.

(-) OMER, Announces public offering of common stock with proceeds to fund two ongoing Phase III clinical trials.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.